Evidence map›Paper›PMID 37868086›Full record

ArticleEJIFCC2023

Evaluation of four quality indicators of the Pre-Analytical Phase External Quality Assessment Subprogram of the Fundación Bioquímica Argentina.

Gisela Unger, Silvia Fabiana Benozzi, Raúl Girardi, Graciela Laura Pennacchiotti

Abstract read
In one paragraph

Article in EJIFCC, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Advances in laboratory medicine · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Gisela UngerCátedra de Bioquímica Clínica I, Departamento de Biología, Bioquímica y Farmacia; Universidad Nacional del Sur; San Juan 670, 8000 Bahía Blanca, Argentina.
Silvia Fabiana BenozziCátedra de Bioquímica Clínica I, Departamento de Biología, Bioquímica y Farmacia; Universidad Nacional del Sur; San Juan 670, 8000 Bahía Blanca, Argentina.
Raúl GirardiExternal Quality Assessment Program, Fundación Bioquímica Argentina, Calle 148 Nº 584, B1900BVK La Plata, Argentina.
Graciela Laura PennacchiottiCátedra de Bioquímica Clínica I, Departamento de Biología, Bioquímica y Farmacia; Universidad Nacional del Sur; San Juan 670, 8000 Bahía Blanca, Argentina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pre-analytical phase external quality assessment programs contribute - through the interlaboratory comparison of quality indicators (QIs) - to the continuous improvement of the clinical laboratory total testing process. The purpose of the present work is to document the results derived from measuring four QIs within the framework of a pre-analytical phase external quality assessment subprogram in Argentina. The laboratories participating in this subprogram measured the following QIs: i) patients recalled for a new blood sample collection due to pre-analytical causes; ii) clotted samples from hemogram and coagulation tests; iii) clinical chemistry hemolyzed samples; and iv) requests with transcription errors entered into the laboratory information system. Results were expressed in percentage value and Sigma value. Databases were anonymized. A minimum acceptable quality level for the four QIs measured was recorded in the majority (75%) of the participating laboratories (Sigma > 3.0). It was nonetheless observed that the QIs of hemolyzed samples and requests with transcription errors entered into the laboratory information system deserve more attention. Through this pioneering experience in Argentina, the participating laboratories - some for the first time - could learn about their performance via interlaboratory comparison of results. This experience also proved to be motivating not only to improve the external assessment subprogram but also to continue working on the measurement of pre-analytical QIs for the continuous improvement of the clinical laboratory total testing process in Argentina.

Indexed as

external quality assessment programspre-analytical phasepre-analytical phase qualityquality indicators

Identifiers

PMID37868086
PMCPMC10588077

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.